{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:01:45Z","timestamp":1791918105527,"version":"4.3.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Donor-specific HLA antibodies (DSA) are associated with increased rates of rejection and of graft failure in cardiac transplantation. The goal of this study was to determine the association of preformed and posttransplant development of newly detected DSA (ndDSA) with antibody-mediated rejection (AMR) and characterize the clinical relevance of complement-activating DSA in heart allograft recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study included 128 adult and 48 pediatric heart transplant patients transplanted between 2010 and 2013. Routine posttransplant HLA antibody testing was performed by IgG single-antigen bead test. The C3d single-antigen bead assay was used to identify complement-activating antibodies. Rejection was diagnosed using International Society for Heart and Lung Transplantation criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In this study, 22 patients were transplanted with preexisting DSA, and 43 patients developed <jats:italic toggle=\"yes\">ndDSA<\/jats:italic> posttransplant. Pretransplant (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and posttransplant (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) ndDSA were associated with higher incidence of AMR. Patients with C3d + DSA had significantly higher incidence of AMR compared with patients with no DSA (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) or patients with C3d-DSA (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02). Nine (36%) of 25 patients with AMR developed transplant coronary artery disease compared with 17 (15.9%) of 107 patients without AMR (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Among the 47 patients who received ventricular assistant device (VAD), 7 of 9 VAD+ patients with preformed DSA experienced AMR compared with 7 of 38 VAD+ patients without preformed DSA, indicating presensitization to donor HLA significantly increased the risk of AMR (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Preformed and posttransplant <jats:italic toggle=\"yes\">ndDSA<\/jats:italic> were associated with AMR. C3d + DSA correlates with complement deposition on the graft and higher risk of AMR which may permit the application of personalized immunotherapy targeting the complement pathway.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002333","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T18:56:59Z","timestamp":1529434619000},"page":"e431-e438","source":"Crossref","is-referenced-by-count":55,"title":["Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients"],"prefix":"10.1097","volume":"102","author":[{"given":"Qiuheng","family":"Zhang","sequence":"first","affiliation":[{"name":"UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hickey","sequence":"additional","affiliation":[{"name":"UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Drogalis-Kim","sequence":"additional","affiliation":[{"name":"Rainbow Babies and Children's Hospital in Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[{"name":"UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gjertson","sequence":"additional","affiliation":[{"name":"UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cadeiras","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam","family":"Khuu","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Baas","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene C.","family":"Depasquale","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Halnon","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Perens","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Alejos","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nsair","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shemin","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ardehali","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.","family":"Reed","sequence":"additional","affiliation":[{"name":"UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","year":"2015","journal-title":"Circulation"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1053-2498(02)00472-2","article-title":"Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease","volume":"22","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1600-6143.2007.01900.x","article-title":"Acute antibody-mediated rejection following heart transplantation","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00007890-199602270-00009","article-title":"Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/petr.12075","article-title":"Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?","volume":"17","year":"2013","journal-title":"Pediatr Transplant"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1600-6143.2009.02748.x","article-title":"Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.tp.0000180564.14050.49","article-title":"The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome","volume":"80","year":"2005","journal-title":"Transplantation"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1309\/AJCPTLBEU5BQ8SHN","article-title":"Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy","volume":"142","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.healun.2012.12.005","article-title":"Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study","volume":"32","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody","volume":"93","year":"2012","journal-title":"Transplantation"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.healun.2015.05.001","article-title":"Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation","volume":"34","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.humimm.2010.09.012","article-title":"Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation","volume":"71","year":"2010","journal-title":"Hum Immunol"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/ajt.14691","article-title":"Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: a report from the CTOTC-04 study","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"bib16-20231002","first-page":"115","article-title":"Heart","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jtcvs.2015.01.003","article-title":"Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient","volume":"149","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MAT.0000000000000053","article-title":"Human leukocyte antigen sensitization in pediatric patients exposed to mechanical circulatory support","volume":"60","year":"2014","journal-title":"ASAIO J"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/j.1600-6143.2005.01074.x","article-title":"Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40472-015-0065-6","article-title":"Antibodies to HLA molecules mimic agonistic stimulation to trigger vascular cell changes and induce allograft injury","volume":"2","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MOT.0b013e328355f1c2","article-title":"HLA class I antibody-mediated endothelial and smooth muscle cell activation","volume":"17","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ajt.12669","article-title":"Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.healun.2009.05.031","article-title":"Utility of virtual crossmatch in sensitized patients awaiting heart transplantation","volume":"28","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","year":"2011","journal-title":"Hum Immunol"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","year":"2012","journal-title":"Pediatr Transplant"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity by de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ki.2013.206","article-title":"Kidney paired donation in the presence of donor-specific antibodies","volume":"84","year":"2013","journal-title":"Kidney Int"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humimm.2008.10.013","article-title":"Peripheral blood B cells producing donor-specific HLA antibodies in vitro","volume":"70","year":"2009","journal-title":"Hum Immunol"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000000545","article-title":"Memory B cells in transplantation","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2015.08.008","article-title":"Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation","volume":"35","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2016.05.001","article-title":"Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant","volume":"35","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1600-6143.2006.01721.x","article-title":"The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","year":"2013","journal-title":"Transplantation"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","article-title":"Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","year":"1996","journal-title":"Science"},{"issue":"1 Suppl","key":"bib44-20231002","first-page":"S33","article-title":"Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration","volume":"82","year":"2006","journal-title":"Transplantation"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.humimm.2011.09.004","article-title":"Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner","volume":"72","year":"2011","journal-title":"Hum Immunol"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ajpath.2011.04.038","article-title":"Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection","volume":"179","year":"2011","journal-title":"Am J Pathol"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/ajt.13273","article-title":"An anti-C1s monoclonal, TNT003, inhibits complement activation induced by antibodies against HLA","volume":"15","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:36:38Z","timestamp":1696224998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002333","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}